Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 6, 2014, Pages 3514-3520

  Tumbarello, Mario ^a   Trecarichi, Enrico Maria ^a   Tumietto, Fabio ^b   Bono, Valerio Del ^c   De Rosa, Francesco Giuseppe ^d   Bassetti, Matteo ^e   Losito, Angela Raffaella ^a   Tedeschi, Sara ^b   Saffioti, Carolina ^c   Corcione, Silvia ^d   Giannella, Maddalena ^b   Raffaelli, Francesca ^a   Pagani, Nicole ^d   Bartoletti, Michele ^b   Spanu, Teresa ^a   Marchese, Anna ^f   Cauda, Roberto ^a   Viscoli, Claudio ^c   Viale, Pierluigi ^b  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e S Maria Hospital   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEMASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CASE CONTROL STUDY; CENTRAL VENOUS CATHETER; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INDWELLING URINARY CATHETER; INFECTION RISK; INTENSIVE CARE UNIT; ITALY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PATIENT IDENTIFICATION; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURGICAL DRAINAGE; COHORT ANALYSIS; ENZYMOLOGY; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; METABOLISM; MICROBIOLOGY; MIDDLE AGED;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FLUOROQUINOLONES; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; ITALY; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84901278928     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02373-13     Document Type: Article

References (35)

1. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791-1798. http://dx.doi.org/10.3201/eid1710.110655.
2. Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos J, Vatopoulos A, Gniadkowski M, Toth A, Pfeifer Y, Jarlier V, Carmeli Y, CNSE Working Group. 2010. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill. 15:19711. http://www.eurosurveillance.org/View Article.aspx?ArticleId-19711.
3. Hirsch EB, Tam VH. 2010. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrugresistant infection. J. Antimicrob. Chemother. 65:1119-1125. http://dx.doi.org/10.1093/ jac/dkq108.
4. Daikos GL, Markogiannakis A. 2011. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? Clin. Microbiol. Infect. 17:1135-1141. http://dx.doi.org/10.1111/j.1469-0691.2011. 03553.x.
5. Akova M, Daikos GL, Tzouvelekis L, Carmeli Y. 2012. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clin. Microbiol. Infect. 18:439-448. http://dx.doi.org/10.1111/j.1469-0691.2012.03823.x.
6. Cantón R, Akóva M, Carmeli Y, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini GM, Samuelsen O, Seifert H, Woodford N, Nordmann P, European Network on Carbapenemases. 2012. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 18:413-431. http://dx.doi.org/10.1111/j.1469-0691.2012. 03821.x.
7. Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Spanu T, Ambretti S, Ginocchio F, Cristini F, Losito AR, Tedeschi S, Cauda R, Bassetti M. 2012. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemaseproducing K. pneumoniae: importance of combination therapy. Clin. Infect. Dis. 55:943-950. http://dx.doi.org/10.1093/ cid/cis588.
8. Gupta N, Limbago BM, Patel JB, Kallen AJ. 2011. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin. Infect. Dis. 53:60-67. http://dx.doi.org/10.1093/cid/cir202.
9. Lee GC, Burgess DS. 2012. Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports. Ann. Clin. Microbiol. Antimicrob. 11:32. http://dx.doi.org/10.1186/ 1476-0711-11-32.
10. Van Duin D, Kaye KS, Neuner EA, Bonomo RA. 2013. Carbapenemresistant Enterobacteriaceae: a review of treatment and outcomes. Diagn. Microbiol. Infect. Dis. 75:115-120. http://dx.doi.org/10.1016/j.diagmicrobio.2012.11.009.
11. Capone A, Giannella M, Fortini D, Giordano A, Meledandri M, Ballardini M, Venditti M, Bordi E, Capozzi D, Balice MP, Tarasi A, Parisi G, Lappa A, Carattoli A, Petrosillo N, SEERBIO-GRAB network. 2013. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin. Microbiol. Infect. 19:E23-E30. http://dx.doi.org/10.1111/1469-0691.12070.
12. Correa L, Martino MD, Siqueira I, Pasternak J, Gales AC, Silva CV, Camargo TZ, Scherer PF, Marra AR. 2013. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. BMC Infect. Dis. 13:80. http://dx.doi.org/10.1186/1471-2334-13-80.
13. Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G, Michalopoulos A. 2007. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case-control study. J. Antimicrob. Chemother. 60:1124-1130. http://dx.doi.org/10.1093/jac/ dkm356.
14. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. 2008. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob. Agents Chemother. 52:1028-1033. http://dx.doi.org/10.1128/AAC.01020- 07.
15. Patel N, Harrington S, Dihmess A, Woo B, Masoud R, Martis P, Fiorenza M, Graffunder E, Evans A, McNutt LA, Lodise TP. 2011. Clinical epidemiology of carbapenem-intermediate or-resistant Enterobacteriaceae. J. Antimicrob. Chemother. 66:1600-1608. http://dx.doi.org/10.1093/jac/dkr156.
16. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. 2008. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect. Control. Hosp. Epidemiol. 29:1099-1106. http://dx.doi.org/10.1086/592412.
17. Orsi GB, Bencardino A, Vena A, Carattoli A, Venditti C, Falcone M, Giordano A, Venditti M. 2013. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study. Infection 41:61-67. http://dx.doi.org/10.1007/s15010-012-0354-2.
18. Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Bartzavali C, Anastassiou ED, Filos KS. 2012. Risk factors for KPCproducing Klebsiella pneumoniae enteric colonization upon ICU admission. J. Antimicrob. Chemother. 67:2976-2981. http://dx.doi.org/10.1093/jac/dks316.
19. Tuon FF, Rocha JL, Toledo P, Arend LN, Dias CH, Leite TM, Penteado-Filho SR, Pilonetto M, Zavascki AP. 2012. Risk factors for KPCproducing Klebsiella pneumonia bacteremia. Braz. J. Infect. Dis. 16:416-419. http://dx.doi.org/10. 1016/j.bjid.2012.08.006.
20. Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. 2009. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase- producing K. pneumoniae. Infect. Control Hosp. Epidemiol. 30: 1180-1185. http://dx.doi.org/10.1086/648451.
21. Sbrana F, Malacarne P, Viaggi B, Costanzo S, Leonetti P, Leonildi A, Casini B, Tascini C, Menichetti F. 2013. Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemaseproducing K. pneumoniae in intensive care unit. Clin. Infect. Dis. 56:697-700. http://dx.doi.org/10.1093/cid/cis969.
22. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. 1988. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 16: 128-140. http://dx.doi.org/10.1016/0196-6553(88)90053-3.
23. Clinical and Laboratory Standard Institute. 2012. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement, M100-S22. CLSI, Wayne, PA.
24. EUCAST. 2013. Breakpoint tables for interpretation of MICs and zone diameters, version 3.1. EUCAST. http://www.eucast.org/antimicrobial- susceptibility-testing/previous-versions-of-tables/.
25. Spanu T, Fiori B, D'Inzeo T, Canu G, Campoli S, Giani T, Palucci I, Tumbarello M, Sanguinetti M, Rossolini GM. 2012. Evaluation of the new NucliSENS EasyQ KPC test for rapid detection of Klebsiella pneumoniae carbapenemase genes (blaKPC). J. Clin. Microbiol. 50:2783-2785. http://dx.doi.org/10.1128/JCM. 00284-12.
26. Rasheed JK, Cockerill F, Tenover FC. 2007. Detection and characterization of antimicrobial resistance genes in pathogenic bacteria, p 1248-1267. In Murray PR, Baron EJ, Jorgensen JH, Landry ML, PfallerMA(ed), Manual of clinical microbiology, 9th ed, vol 1. ASM Press, Washington, DC.
27. European Centre for Disease Prevention and Control. 2008. Annual epidemiological report on communicable diseases in Europe 2008, p 16-38. European Centre for Disease Prevention and Control, Stockholm, Sweden. http://ecdc.europa.eu/en/publications/Publications/0812-SUR-Annual- Epidemiological-Report-2008.pdf.
28. Charlson ME, Pompei P, Ales KL, MacKenzie CR. 1987. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J. Chron. Dis. 40:373-383. http://dx.doi.org/10.1016/0021-9681(87) 90171-8.
29. Mendes RE, Bell JM, Turnidge JD, Yang Q, Yu Y, Sun Z, Jones RN. 2008. Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene. Antimicrob. Agents Chemother. 52:798-799. http://dx.doi.org/10.1128/AAC.01185-07.
30. Trecarichi EM, Cauda R, Tumbarello M. 2012. Detecting risk and predicting patient mortality in patients with extended-spectrum-lactamase-producing Enterobacteriaceae bloodstream infections. Future Microbiol. 7:1173-1189. http://dx.doi.org/10.2217/fmb.12.100.
31. Tumbarello M, Trecarichi EM, Bassetti M, De Rosa FG, Spanu T, Di Meco E, Losito AR, Parisini A, Pagani N, Cauda R. 2011. Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrob. Agents Chemother. 55:3485-3490. http://dx.doi.org/10.1128/AAC.00009-11.
32. Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D'Inzeo T, Fadda G, Cauda R, Spanu T. 2007. Predictors of mortality in patients with bloodstream infections caused by extendedspectrum- beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob. Agents Chemother. 51: 1987-1994. http://dx.doi.org/10.1128/AAC.01509-06.
33. Viale P, Giannella M, Lewis R, Trecarichi EM, Petrosillo N, Tumbarello M. 2013. Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections. Expert Rev. Anti Infect. Ther. 11:1053-1063. http://dx.doi.org/10.1586/14787210.2013.836057.
34. Bassetti M, Trecarichi EM, Mesini A, Spanu T, Giacobbe DR, Rossi M, Shenone E, Pascale GD, Molinari MP, Cauda R, Viscoli C, Tumbarello M. 2012. Risk factors and mortality of healthcare-Associated and community-Acquired Staphylococcus aureus bacteraemia. Clin. Microbiol. Infect. 18:862-869. http://dx.doi.org/10.1111/j.1469-0691.2011.03679.x.
35. Tumbarello M, De Pascale G, Trecarichi EM, Spanu T, Antonicelli F, Maviglia R, Pennisi MA, Bello G, Antonelli M. 2013. Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients. Intensive Care Med. 39:682-692. http://dx.doi.org/10.1007/s00134-013-2828-9.